Acute central administration of MCH stimulates food intake in rodents (Qu et al. 1996) while chronic central infusion leads to obesity and insulin resistance (Della-Zuana et al. 2002; Gomori et al. 2003). Here, PMCH is linked to obesity due to melanocortin 4 receptor deficiency.